Literature DB >> 19198665

Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis.

John D Young1, Jan Martel, Lena Young, Cheng-Yeu Wu, Andrew Young, David Young.   

Abstract

Putative living entities called nanobacteria (NB) are unusual for their small sizes (50-500 nm), pleomorphic nature, and accumulation of hydroxyapatite (HAP), and have been implicated in numerous diseases involving extraskeletal calcification. By adding precipitating ions to cell culture medium containing serum, mineral nanoparticles are generated that are morphologically and chemically identical to the so-called NB. These nanoparticles are shown here to be formed of amorphous mineral complexes containing calcium as well as other ions like carbonate, which then rapidly acquire phosphate, forming HAP. The main constituent proteins of serum-derived NB are albumin, fetuin-A, and apolipoprotein A1, but their involvement appears circumstantial since so-called NB from different body fluids harbor other proteins. Accordingly, by passage through various culture media, the protein composition of these particles can be modulated. Immunoblotting experiments reveal that antibodies deemed specific for NB react in fact with either albumin, fetuin-A, or both, indicating that previous studies using these reagents may have detected these serum proteins from the same as well as different species, with human tissue nanoparticles presumably absorbing bovine serum antigens from the culture medium. Both fetal bovine serum and human serum, used earlier by other investigators as sources of NB, paradoxically inhibit the formation of these entities, and this inhibition is trypsin-sensitive, indicating a role for proteins in this inhibitory process. Fetuin-A, and to a lesser degree albumin, inhibit nanoparticle formation, an inhibition that is overcome with time, ending with formation of the so-called NB. Together, these data demonstrate that NB are most likely formed by calcium or apatite crystallization inhibitors that are somehow overwhelmed by excess calcium or calcium phosphate found in culture medium or in body fluids, thereby becoming seeds for calcification. The structures described earlier as NB may thus represent remnants and by-products of physiological mechanisms used for calcium homeostasis, a concept which explains the vast body of NB literature as well as explains the true origin of NB as lifeless protein-mineralo entities with questionable role in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19198665      PMCID: PMC2636888          DOI: 10.1371/journal.pone.0004417

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  66 in total

1.  Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis.

Authors:  Yu Wen; Yong-guo Li; Zhu-lin Yang; Xue-jun Wang; Hong Wei; Wei Liu; Xiong-ying Miao; Qun-wei Wang; Sheng-fu Huang; Jing Yang; E Olavi Kajander; Neva Ciftcioglu
Journal:  Chin Med J (Engl)       Date:  2005-03-05       Impact factor: 2.628

Review 2.  Drug insight: the role of albumin in the management of chronic liver disease.

Authors:  Florence Wong
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2007-01

Review 3.  Can biologic nanoparticles initiate nephrolithiasis?

Authors:  John C Lieske
Journal:  Nat Clin Pract Nephrol       Date:  2008-03-18

4.  Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization.

Authors:  G Hudelist; C F Singer; E Kubista; M Manavi; R Mueller; K Pischinger; K Czerwenka
Journal:  Histopathology       Date:  2004-12       Impact factor: 5.087

5.  Apatite precipitation after incubation of biphasic calcium-phosphate ceramic in various solutions: influence of seed species and proteins.

Authors:  R Rohanizadeh; M Padrines; J M Bouler; D Couchourel; Y Fortun; G Daculsi
Journal:  J Biomed Mater Res       Date:  1998-12-15

6.  Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves.

Authors:  Virginia M Miller; George Rodgers; Jon A Charlesworth; Brenda Kirkland; Sandra R Severson; Todd E Rasmussen; Marineh Yagubyan; Jeri C Rodgers; Franklin R Cockerill; Robert L Folk; Ewa Rzewuska-Lech; Vivek Kumar; Gerard Farell-Baril; John C Lieske
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-13       Impact factor: 4.733

7.  Nacre surface transformation to hydroxyapatite in a phosphate buffer solution.

Authors:  Ming Ni; Buddy D Ratner
Journal:  Biomaterials       Date:  2003-10       Impact factor: 12.479

8.  Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population.

Authors:  Madhu Khullar; S K Sharma; S K Singh; Pratibha Bajwa; Farooq A Shiekh; Farooq A Sheikh; Vandana Relan; Meera Sharma
Journal:  Urol Res       Date:  2004-02-06

9.  Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.

Authors:  Alexander Heiss; Alexander DuChesne; Bernd Denecke; Joachim Grötzinger; Kazuhiko Yamamoto; Thomas Renné; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

10.  Search for past life on Mars: possible relic biogenic activity in martian meteorite ALH84001.

Authors:  D S McKay; E K Gibson; K L Thomas-Keprta; H Vali; C S Romanek; S J Clemett; X D Chillier; C R Maechling; R N Zare
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

View more
  33 in total

Review 1.  A red herring in vascular calcification: 'nanobacteria' are protein-mineral complexes involved in biomineralization.

Authors:  Georg Schlieper; Thilo Krüger; Alexander Heiss; Willi Jahnen-Dechent
Journal:  Nephrol Dial Transplant       Date:  2011-09-29       Impact factor: 5.992

2.  Critical evaluation of gamma-irradiated serum used as feeder in the culture and demonstration of putative nanobacteria and calcifying nanoparticles.

Authors:  Jan Martel; Cheng-Yeu Wu; John D Young
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

3.  Membrane vesicles nucleate mineralo-organic nanoparticles and induce carbonate apatite precipitation in human body fluids.

Authors:  Cheng-Yeu Wu; Jan Martel; Wei-Yun Cheng; Chao-Chih He; David M Ojcius; John D Young
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

4.  Nanoparticle-based test measures overall propensity for calcification in serum.

Authors:  Andreas Pasch; Stefan Farese; Steffen Gräber; Johanna Wald; Walter Richtering; Jürgen Floege; Willi Jahnen-Dechent
Journal:  J Am Soc Nephrol       Date:  2012-09-06       Impact factor: 10.121

5.  Waiting for Aπαταω: 250 Years Later.

Authors:  Victoria Wu; Vuk Uskoković
Journal:  Found Sci       Date:  2019-04-03       Impact factor: 1.238

6.  Proteomic evaluation of biological nanoparticles isolated from human kidney stones and calcified arteries.

Authors:  Farooq A Shiekh; Jon E Charlesworth; Sung-Hoon Kim; Larry W Hunter; Muthuvel Jayachandran; Virginia M Miller; John C Lieske
Journal:  Acta Biomater       Date:  2010-05-11       Impact factor: 8.947

7.  Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept.

Authors:  Cheng-Yeu Wu; Jan Martel; David Young; John D Young
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

8.  Characterization of biofilm formed by human-derived nanoparticles.

Authors:  Maria K Schwartz; Larry W Hunter; Marianne Huebner; John C Lieske; Virginia M Miller
Journal:  Nanomedicine (Lond)       Date:  2009-12       Impact factor: 5.307

9.  Biologic nanoparticles and platelet reactivity.

Authors:  Virginia M Miller; Larry W Hunter; Kevin Chu; Vivasvat Kaul; Phillip D Squillace; John C Lieske; Muthuvel Jayachandran
Journal:  Nanomedicine (Lond)       Date:  2009-10       Impact factor: 5.307

Review 10.  Contribution of biologically derived nanoparticles to disease.

Authors:  Maria K Schwartz; John C Lieske; Virginia M Miller
Journal:  Surgery       Date:  2009-09-20       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.